| Guidelines and considerations for testing malaria vaccines in pregnant women. | |
| | |
MedLine Citation:
|
PMID: 19946207 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Malaria during pregnancy continues to be an important cause of maternal and infant morbidity and mortality in endemic areas, where at least 50 million pregnancies are exposed to the infection every year. Important progress has been made in the last years especially in sub-Saharan Africa, with the introduction of strategies to prevent malaria in pregnancy consisting of intermittent preventive treatment and insecticide treated nets. However, their coverage is still unacceptably low and malaria continues to demand a huge toll on pregnant women and their newborns. Thus, there is a need to explore other preventive strategies such as a vaccine against malaria, which combined with the current tools would maximize the protection efficacy. Given the specific and complex characteristics of the pregnancy status, it is important to review all the issues that would need to be considered in the evaluation of a vaccine against malaria in pregnancy while waiting for it to become available. |
| | |
Authors:
|
Clara Menendez; Pedro Alonso; Universitat de Barcelona |
Related Documents
:
|
4606777 - Malaria transmission and fetal growth. 21387087 - Effect of pre-pregnancy body mass index and weight gain during pregnancy on the risk of... 19867927 - The diagnostic value of the placental blood film in aestivo-autumnal malaria. 11262037 - Changes in chloroplast pigments of olive varieties during fruit ripening. 18638107 - Non-invasive monitoring of hormones: a tool to improve reproduction in captive breeding... 16119247 - Snakebite during pregnancy. |
Publication Detail:
|
Type: Guideline; Journal Article; Review Date: 2010-01-15 |
Journal Detail:
|
Title: Human vaccines Volume: 6 ISSN: 1554-8619 ISO Abbreviation: Hum Vaccin Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-04-20 Completed Date: 2010-07-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101265291 Medline TA: Hum Vaccin Country: United States |
Other Details:
|
Languages: eng Pagination: 21-6 Citation Subset: IM |
Affiliation:
|
Barcelona Center for International Health Research (CRESIB), Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Spain. clara.menendez@cresib.cat |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Africa South of the Sahara Clinical Trials as Topic Female Humans Malaria / epidemiology*, prevention & control* Malaria Vaccines / adverse effects*, immunology* Pregnancy Pregnancy Complications, Infectious / epidemiology*, prevention & control* |
| Chemical | |
Reg. No./Substance:
|
0/Malaria Vaccines |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: ABP1: An auxin receptor for fast responses at the plasma membrane.
Next Document: High titer human immunoglobulin as a specific therapy against West Nile virus encephalitis.